S100A9 extends lifespan in insulin deficiency
Open Access
- 7 August 2019
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-12
Abstract
Tens of millions suffer from insulin deficiency (ID); a defect leading to severe metabolic imbalance and death. The only means for management of ID is insulin therapy; yet, this approach is sub-optimal and causes life-threatening hypoglycemia. Hence, ID represents a great medical and societal challenge. Here we report that S100A9, also known as Calgranulin B or Myeloid-Related Protein 14 (MRP14), is a leptin-induced circulating cue exerting beneficial anti-diabetic action. In murine models of ID, enhanced expression of S100A9 alone (i.e. without administered insulin and/or leptin) slightly improves hyperglycemia, and normalizes key metabolic defects (e.g. hyperketonemia, hypertriglyceridemia, and increased hepatic fatty acid oxidation; FAO), and extends lifespan by at least a factor of two. Mechanistically, we report that Toll-Like Receptor 4 (TLR4) is required, at least in part, for the metabolic-improving and pro-survival effects of S100A9. Thus, our data identify the S100A9/TLR4 axis as a putative target for ID care.Keywords
This publication has 53 references indexed in Scilit:
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial FunctionCell Metabolism, 2012
- Metabolic actions of hypothalamic SIRT1Trends in Endocrinology & Metabolism, 2012
- S100A8 and S100A9 in Cardiovascular Biology and DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Discovery and Validation of Serum Protein Changes in Type 1 Diabetes Patients Using High Throughput Two Dimensional Liquid Chromatography-Mass Spectrometry and ImmunoassaysMolecular & Cellular Proteomics, 2011
- SIRT1 Deacetylase in SF1 Neurons Protects against Metabolic ImbalanceCell Metabolism, 2011
- Leptin is an effective treatment for hypothalamic amenorrheaProceedings of the National Academy of Sciences, 2011
- Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in miceProceedings of the National Academy of Sciences of the United States of America, 2010
- Leptin therapy in insulin-deficient type I diabetesProceedings of the National Academy of Sciences of the United States of America, 2010
- Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cellsNature Protocols, 2009
- Making insulin-deficient type 1 diabetic rodents thrive without insulinProceedings of the National Academy of Sciences, 2008